Botulism Diagnostics: From Clinical Symptoms to in vitro Assays

REFERENCES

• Adams A., Thompson K.D. Biotechnology offers revolution to fish health management. Trends Biotechnol. 2006; 24: 201–205
   PubMed Web of Science ®Google Scholar
• Ahn-Yoon S., DeCory T.R., Durst R.A. Ganglioside-liposome immunoassay for the detection of botulinum toxin. Anal. Bio. 2004; 378: 68–75
   Google Scholar
• AOAC International. AOAC official method 977.26 (Sec. 17.7.01) Clostridium botulinum and its toxins in foods. Official Methods of Analysis17th Ed. AOAC International, Gaithersburg, MD 2001
   Google Scholar
• Arnon S.S., Schechter R., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Fine A.D., Hauer J., Layton M., Lillibridge S., Osterholm M.T., O’Toole T., Parker G., Perl T.M., Russell P.K., Swerdlow D.L., Tonat K. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001; 285: 1059–1070
   PubMed Web of Science ®Google Scholar
• Arnon S.S., Schechter R., Maslanka S.E., Jewell N.P., Hatheway C.L. Human botulism immune globulin for the treatment of infant botulism. N. Engl. J. Med. 2006; 354: 462–471
   PubMed Web of Science ®Google Scholar
• Barr J.R., Moura H., Boyer A.E., Woolfitt A.R., Kalb S.R., Pavlopoulos A., McWilliams L.G., Schmidt J.G., Martinez R.A., Ashley D.L. Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg. Infect. Dis. 2005; 11: 1578–1583
   PubMed Web of Science ®Google Scholar
• Binz T., Blasi J., Yamasaki S., Baumeister A., Link E., Sudhof T.C., Jahn R., Niemann H. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem 1994; 269: 1617–1620
   PubMed Web of Science ®Google Scholar
• Blasi J., Chapman E.R., Link E., Binz T., Yamasaki S., Camilli P., Sudhof T.C., Niemann H., Jahn R. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP–25. Nature 1993; 365: 160–163
   PubMed Web of Science ®Google Scholar
• Blasi J., Chapman E.R., Link E., Binz T., Yamasaki S., De Camilli P., Sudhof T.C., Niemann H., Jahn R. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J. 1993; 12: 4821–4828
   PubMed Web of Science ®Google Scholar
• Boldt G.E., Eubanks L.M., Janda K.D. Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model. Chem Commun (Camb) 2006; 29: 3063–3065
   Google Scholar
• Boroff D., Fleck U. Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum. J Bacteriol 1966; 92: 1580–1581
   Google Scholar
• Boyer A.E., Moura H., Woolfitt A.R., Kalb S.R., McWilliams L.G., Pavlopoulos A., Schmidt J.G., Ashley D.L., Barr J.R. From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry. Anal Chem 2005; 77: 3916–3924
   PubMed Web of Science ®Google Scholar
• Cai S, Kukreja R., Shoesmith S., Chang T.W., Singh B.R. Botulinum Neurotoxin Light Chain Refolds at Endosomal pH for its Translocation. Protein J 2006; 25: 455–462
   PubMed Web of Science ®Google Scholar
• Cai S., Singh B.R. Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreito. Biochemistry 1999; 38: 6903–6910
   Google Scholar
• Centers for Disease Control and Prevention. Botulism in the United States. 1998; 1899–1996
   Google Scholar
• Chia J.K., Clark J.B., Ryan C.A., Pollack M. Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum. N. Engl. J. Med 1986; 315: 239–240
   Google Scholar
• Clapp A.R., Medintz I.L., Uyeda H.T., Fisher B.R., Goldman E.R., Bawendi M.G., Mattoussi H. Quantum dot–based multiplexed fluorescence resonance energy transfer. J Am Chem Soc 2005; 127: 18212–18221
   PubMed Web of Science ®Google Scholar
• Cooper J.G., Spilke C.E., Denton M., Jamieson S. Clostridium botulinum: an increasing complication of heroin misuse. Eur J Emerg Med 2005; 12: 251–252
   Google Scholar
• Deregt D., Gilbert S.A., Dudas S., Pasick J., Baxi S., Burton K.M., Baxi M.K. A multiplex DNA suspension microarray for simultaneous detection and differentiation of classical swine fever virus and other pestiviruses. J Virol Methods 2006; 136: 17–23
   PubMed Web of Science ®Google Scholar
• Dezfulian M., Bartlett J.G. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals. J Clin Microbiol 1984; 19: 645–648
   PubMed Web of Science ®Google Scholar
• Dezfulian M., Hatheway C.L., Yolken R.H., Bartlett J.G. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type A and type B toxins in stool samples of infants with botulism. J Clin Microbiol 1984; 20: 379–383
   Google Scholar
• Doellgast G.J., Triscott M.X., Beard G.A., Bottoms J.D., Cheng T., Roh B.H., Roman M.G., Hall P.A., Brown J.E. Sensitive enzyme-linked immunosorbent assay for the detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme-linked coadulation assay. J. Clin. Microbiol. 1993; 31: 2402–2409
   Google Scholar
• Dong M., Richards D.A., Goodnough M.C., Tepp W.H., Johnson E.A., Chapman E.R. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol. 2003; 162: 1293–1303
   PubMed Web of Science ®Google Scholar
• Dong M., Tepp W.H., Johnson E.A., Chapman E.R. Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells. Proc Natl Acad Sci USA 2004; 101: 14701–14706
   PubMed Web of Science ®Google Scholar
• Dong M., Yeh F., Tepp W.H., Dean C., Johnson E.A., Janz R., Chapman E.R. SV2 is the protein receptor for botulinum neurotoxin A. Science 2006; 312: 592–596
   PubMed Web of Science ®Google Scholar
• Dunbar S.A. Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin Chim Acta 2006; 363: 71–82
   PubMed Web of Science ®Google Scholar
• Fenicia L., Franciosa G., Pourshaban M., Aureli P. Intestinal toxemia botulism in two young people, caused by Clostridium butyricum type E. Clin. Infect. Dis. 1999; 29: 1381–1387
   Google Scholar
• Ferreira J.L. Comparison of amplified ELISA and mouse bioassay procedures for detection of botulinal toxins A, B, E, and F. J. AOAC Int 2001; 84: 85–88
   PubMed Web of Science ®Google Scholar
• Ferreira J.L., Eliasberg S.J. Detection of preformed type A botulinal toxin in harsh brown potatoes by using the mouse bioassay and a modified ELISA test. J. AOAC Int. 2001; 84: 1460–1464
   Google Scholar
• Ferreira J.L., Maslanka S., Johnson E., Goodnough M. Detection of botulinal toxins A, B, E, and F by amplified enzyme-linked immunosorbent assay: collaborative study. J. AOAC Int. 2003; 86: 314–331
   Google Scholar
• Foran P., Lawrence G.W., Shone C.C., Foster K.A., Dolly J.O. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry 1996; 35: 2630–2636
   PubMed Web of Science ®Google Scholar
• Freedman M., Armstrong R. M., Killian J. M., Bolland D. Botulism in a patient with jejunoileal bypass. Ann. Neurol. 1986; 20: 641–643
   PubMed Web of Science ®Google Scholar
• Fu F.N., Lomneth R.B., Cai S., Singh B.R. Role of zinc in the structure and toxic activity of botulinum neurotoxin. Biochemistry 1998; 37: 5267–5278
   Google Scholar
• Fujinaga Y., Takeshi K., Inoue K., Fujita R., Ohyama T., Moriishi K., Oguma K. Type A and B neurotoxin genes in a Clostridium botulinum type AB strain. Biochem. and Biophys. Res. Commun. 1995; 213: 737–745
   Google Scholar
• Gatto-Menking D.L., Yu H., Bruno J.G., Goode M.T., Miller M., Zulich A.W. Sensitive detection of biotoxoids and bacterial spores using an immunomagnetic electrochemiluminescence sensor. Biosens. Bioelectron. 1995; 10: 501–507
   PubMed Web of Science ®Google Scholar
• Georganopoulou D.G., Chang L., Nam J.M., Thaxton C.S., Mufson E.J., Klein W.L., Mirkin C.A. Nanoparticle–based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc Natl Acad Sci USA 2005; 102: 2273–2276
   PubMed Web of Science ®Google Scholar
• Goldman E.R., Clapp A.R., Anderson G.P., Uyeda H.T., Mauro J.M., Medintz I.L., Mattoussi H. Multiplexed toxin analysis using four colors of quantum dot fluororeagents. Anal Chem 2004; 76: 684–688
   PubMed Web of Science ®Google Scholar
• Goldman E.R., Mattoussi H., Anderson G.P., Medintz I.L, Mauro J.M. Fluoroimmunoassays using antibody-conjugated quantum dots. Methods Mol Biol 2005; 303: 19–34
   PubMedGoogle Scholar
• Goluch E.D., Nam J.M., Georganopoulou D.G., Chiesl T.N., Shaikh K.A., Ryu K.S., Barron A.E., Mirkin C.A., Liu C. A bio-barcode assay for on-chip attomolar-sensitivity protein detection. Lab Chip 2006; 6: 1293–1299
   PubMed Web of Science ®Google Scholar
• Greenfield R.A., Brown B.R., Hutchins J.B., Iandolo J.J., Jackson R., Slater L.N., Bronze M.S. Microbiological, biological, and chemical weapons of warfare and terrorism. Am. J. Med. Sci. 2002; 323: 326–340
   PubMed Web of Science ®Google Scholar
• Grumelli C., Verderio C., Pozzi D., Rossetto O., Montecucco C., Matteoli M. Internalization and mechanism of action of clostridial toxins in neurons. Neurotoxicology 2005; 26: 761–767
   PubMed Web of Science ®Google Scholar
• Guglielmo-Viret V., Attree O., Blanco-Gros V., Thullier P. Comparison of electrochemiluminescence assay and ELISA for the detection of Clostridium botulinum type B neurotoxin. J. Immunol. Methods. 2005; 301: 164–172
   Google Scholar
• Gupta A., Sumner C.J., Castor M., Maslanka S., Sobel J. Adult botulism type F in the United States, 1981–2002. Neurology 2005; 65: 1694–1700
   Google Scholar
• Haab B. B. Methods and applications of antibody microarrays in cancer research. Proteomics 2003; 3: 2116–2122
   PubMed Web of Science ®Google Scholar
• Hall J.D., McCroskey L.M., Pincomb B.J., Hatheway C.L. Isolation of an organism resembling Clostridium baratii which produces type F botulinal toxin from an infant with botulism. J. Clin. Microbiol. 1985; 21: 654–655
   Google Scholar
• Harwanegg C, Hiller R. Protein microarrays in diagnosing IgE-mediated diseases: spotting allergy at the molecular level. Expert. Rev. Mol. Diagn. 2004; 4: 539–548
   PubMed Web of Science ®Google Scholar
• Inoue K., Fujinaga Y., Watanabe T., Ohyama T., Takeshi K., Moriishi K., Nakajima H., Inoue K., Oguma K. Molecular composition of Clostridium botulinum type A progenitor toxins. Infect. Immun. 1996; 64: 1589–1594
   PubMed Web of Science ®Google Scholar
• Isacsohn M., Cohen A., Steiner P., Rosenberg P., Rudensky B. Botulism intoxication after surgery in the gut. Israel J. Med. Sci. 1985; 21: 150–153
   Google Scholar
• Jayasena S.D. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clinical Chem 1999; 45: 1628–1650
   PubMed Web of Science ®Google Scholar
• Jenison R.D., Gill S.C., Pardi A., Polisky B. High-Resolution molecular discrimination by RNA. Science 1994; 263: 1425–1429
   PubMed Web of Science ®Google Scholar
• Johnson E.A., Bradshaw M. Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective. Toxicon 2001; 39: 1703–1722
   PubMed Web of Science ®Google Scholar
• Jung R., Soondrum K., Neumaier M. Quantitative PCR. Clin. Chem. Lab Med. 2000; 38: 833–836
   PubMed Web of Science ®Google Scholar
• Kalb S.R., Goodnough M.C., Malizio C.J., Pirkle J.L., Barr J.R. Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics. Anal. Chem. 2005; 77: 6140–6146
   PubMed Web of Science ®Google Scholar
• Kalb S.R., Moura H., Boyer A.E., McWilliams L.G., Pirkle J.L., Barr J.R. The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples. Anal. Biochem. 2006; 351: 84–92
   PubMed Web of Science ®Google Scholar
• Keller J.E., Cai F., Neale E.A. Uptake of botulinum neurotoxin into cultured neurons. Biochemistry 2004; 43: 526–532
   PubMed Web of Science ®Google Scholar
• Koriazova L.K., Montal M. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat. Struct. Biol. 2003; 10: 13–18
   PubMedGoogle Scholar
• Kozaki S., Kamata Y., Takahashi M., Shimizu T., Sakaguchi G. Antibodies against botulinum neurotoxin. Botulinum Neurotoxin and Tetanus Toxin, L.L. Simpson. Academic Press, San Diego 1989; 301–318
   Google Scholar
• Lebeda F.J., Singh B.R. Membrane channel activity and translocation of tetanus and botulinum neurotoxins. J. Toxicol.–Toxin Reviews. 1999; 18: 45–76
   Google Scholar
• Lee S.-W., Sullenger B.A. Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies. Nat. Biotech. 1997; 15: 41–45
   PubMed Web of Science ®Google Scholar
• Li L., Singh B.R. Structure-function relationship of clostridial neurotoxins. J. Toxicol.–Toxin Reviews. 1999; 18: 95–112
   Google Scholar
• Li L., Singh B.R. Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay. J. Nat. Toxins. 1998; 7: 215–226
   PubMedGoogle Scholar
• Li L., Singh B.R. Spectroscopic analysis of pH-induced changes in the molecular features of type A botulinum neurotoxin light chain. Biochemistry 2000; 39: 6466–6474
   PubMedGoogle Scholar
• Ligler F.S., Taitt C.R., Shriver-Lake L.C., Sapsford K.E., Shubin Y., Golden J.P. Array biosensor for detection of toxins. Anal. Bio. 2003; 377: 469–477
   Google Scholar
• Lim D.V. Detection of microorganisms and toxins with evanescent wave fiber–optic biosensors. Proc. IEEE. 2003; 91: 902–907
   Web of Science ®Google Scholar
• Lizard P.M., Huang X., Zhu Z., Bray-Ward P., Thomas D.C., Ward D.C. Mutation detection and single molecule counting using isothermal rolling circle amplification. Nat. Genet 1998; 19: 225–232
   Google Scholar
• Lomneth R., Martin T.F., DasGupta B.R. Botulinum neurotoxin light chain inhibits norepinephrine secretion in PC12 cells at an intracellular membranous or cytoskeletal site. J. Neurochem. 1991; 57: 1413–1421
   Google Scholar
• Ma H., Zhou B., Kim Y., Janda K.D. A cyclic peptide–polymer probe for the detection of Clostridium botulinum neurotoxin serotype A. Toxicon. 2006 2006; 47: 901–908
   Google Scholar
• MacDonald K.L., Rutherford G.W., Friedman S.M., Dietz J.R., Kaye B.R., McKinley G.F., Tenney J.H., Cohen M.L. Botulism and botulism-like illness in chronic drug abusers. Ann. Intern. Med. 1985; 102: 616–618
   Google Scholar
• Mason J.T., Xu L., Sheng Z.M., O’Leary T.J. A liposome-PCR assay for the ultrasensitive detection of biological toxins. Nat. Biotechnol. 2006; 24: 555–557
   PubMed Web of Science ®Google Scholar
• McCroskey L.M., Hatheway C.L. Laboratory findings in four cases of adult botulism suggest colonization of the intestinal tract. J. Clin. Microbiol. 1988; 26: 1052–1054
   PubMed Web of Science ®Google Scholar
• McCroskey L.M., Hatheway C.L., Fenicia L., Paasolini B., Aureli P. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J. Clin. Microbiol. 1986; 23: 201–202
   Google Scholar
• Midura T.F., Arnon S.S. Infant botulism. Identification of Clostridium botulinum and its toxin in faeces. Lancet 1976; 2: 934–936
   PubMed Web of Science ®Google Scholar
• Montecucco C. How do tetanus and botulinum toxins bind to neuronal membrane. Trends Biochem. Sci 1986; 11: 314–317
   Web of Science ®Google Scholar
• Montecucco C., Molgo J. Botulinal neurotoxins: revival of an old killer. Curr. Opin. Pharmacol. 2005; 5: 274–279
   PubMed Web of Science ®Google Scholar
• Montecucco C., Rossetto O., Schiavo G. Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol 2004; 12: 442–446
   PubMed Web of Science ®Google Scholar
• Montecucco C., Schiavo G. Structure and function of tetanus and botulinum neurotoxins. Quart. Rev. Biophys. 1996; 28: 423–472
   Google Scholar
• Moriishi K., Koura M., Fujii N., Fujinaga Y., Igoue K., Syuto B., Oguma K. Molecular cloning of the gene encoding the mosaic neurotoxin, composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms. App. Environ. Microbio. 1996; 62: 662–667
   PubMed Web of Science ®Google Scholar
• Nam J.M., Stoeva S.I., Mirkin C.A. Bio-bar-code-based DNA detection with PCR–like sensitivity. J Am Chem Soc 2004; 126: 5932–5933
   PubMed Web of Science ®Google Scholar
• Nam J.M., Thaxton C.S., Mirkin C.A. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 2003; 301: 1884–1886
   PubMed Web of Science ®Google Scholar
• Niemeyer C.M., Adler M., Wacker R. Immuno-PCR: high sensitivity detection of proteins by nucleic acid amplification. Trends Biotechnol. 2005 2005; 23: 208–216
   PubMed Web of Science ®Google Scholar
• Nishiki T., Kamata Y., Nemoto Y., Omori A., Ito T., Takahashi M., Kozaki S. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J. Biol. Chem 1994; 269: 10498–10503
   PubMed Web of Science ®Google Scholar
• Nishiki T., Tokuyama Y., Kamata Y., Nemoto Y., Yoshida A., Sato K., Sekiguchi M., Takahashi M., Kozaki S. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett 1996; 378: 253–257
   PubMed Web of Science ®Google Scholar
• Nishiki T., Tokuyama Y., Kamata Y., Nemoto Y., Yoshida A., Sekiguchi M., Takahashi M., Kozaki S. Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA. Neurosci. Lett. 1996; 208: 105–108
   Google Scholar
• Ogert R.A., Brown J.E., Singh B.R., Shriver-Lake L.C., Ligler F.S. Detection of Clostridium botulinum toxin A using a fiber optic-based biosensor. Anal. Biochem. 1992; 205: 306–312
   PubMed Web of Science ®Google Scholar
• Pang S., Smith J., Onley D., Reeve J., Walker M., Foy C. A comparability study of the emerging protein array platforms with established ELISA procedures. J Immunol Methods. 2005; 302: 1–12
   PubMed Web of Science ®Google Scholar
• Poli M.A., Rivera V.R., Neal D. Development of sensitive colorimetric capture ELISAs for Clostridium botulinum neurotoxin serotypes E and F. Toxicon 2002; 40: 797–802
   PubMed Web of Science ®Google Scholar
• Potter M., Meng J., Kimsey P. An ELISA for detection of botulinal toxin types A, B, and E in inoculated food samples. J. Food Protection. 1993; 56: 856–861
   Google Scholar
• Puffer E.B., Lomneth R.B., Sarkar H.K., Singh B.R. Differential roles of developmentally distinct SNAP-25 isoforms in the neurotransmitter release process. Biochemistry 2001; 40: 9374–9378
   Google Scholar
• Purkiss J.R., Friis L.M., Doward S., Quinn C.P. Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells. Neurotoxicology 2001; 22: 447–453
   PubMed Web of Science ®Google Scholar
• Qian S., Bau H.H. A mathematical model of lateral flow bioreactions applied to sandwich assays. Anal. Biochem. 2003; 322: 89–98
   PubMed Web of Science ®Google Scholar
• Rivera V.R., Gamez F.J., Keener W.K., White J.A., Poli M.A. Rapid detection of Clostridium botulinum toxins A, B, E, and F in clinical samples, selected food matrices, and buffer using paramagnetic bead-based electrochemiluminescence detection. Anal. Biochem. 2006; 353: 248–256
   Google Scholar
• Rong-Hwa S., Huey-Fen S., Hwan-Wun L., Shiao-Shek T. Colloidal gold–based immunochromatographic assay for detection of ricin. Toxicon 2002; 40: 255–258
   Google Scholar
• Rouquette A.M., Desgruelles C., Laroche P. Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. Am J Clin Pathol 2003; 120: 676–681
   PubMed Web of Science ®Google Scholar
• Rummel A., Karnath T., Henke T., Bigalke H., Binz T. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J Biol Chem 2004; 279: 30865–30870
   PubMed Web of Science ®Google Scholar
• Rusconi C.P., Scardino E., Layzer J., Pitoc G.A., Ortel T.L., Monroe D., Sullenger B.A. RNA aptamers as reversible antagonists of coagulation factor Ixa. Nature 2002; 419: 90–94
   PubMed Web of Science ®Google Scholar
• Sangsuk L., Kools J., Andreadis J., Khumthalang T., Suthiwarakom K., Jittaprasartsilp C., Sawanpunyalert P., Peruski L., Maslanka S. Laboratory aspects of an outbreak of Clostridium botulinum in northern Thailand, 2006. The 43rd Interagency Botulism Research Coordinating Committee Meeting. Silver Spring, MD 2006, November 14–16, 2006
   Google Scholar
• Sano T., Smith C.L., Cantor C.R. Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates. Science 1992; 258: 120–122
   PubMed Web of Science ®Google Scholar
• Sapsford K.E., Taitt C.R., Loo N., Ligler F.S. Biosensor detection of botulinum toxoid A and staphylococcal enterotoxin B in food. Appl. Environ. Microbiol. 2005; 71: 5590–5592
   PubMed Web of Science ®Google Scholar
• Schiavo G., Benfenati F., Poulain B., Rossetto O., Polverino deLaureto P., DasGupta B.R., Montecucco C. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992; 359: 832–835
   PubMed Web of Science ®Google Scholar
• Schiavo G., Malizio C., Trimble W.S., Polverino deLaureto P., Milan G., Sugiyama H., Johnson E.A., Montecucco C. Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond. J. Biol. Chem. 1994; 269: 20213–20216
   PubMed Web of Science ®Google Scholar
• Schiavo G., Poulain B., Rossetto O., Benfenati F., Tauc L., Montecucco C. Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc. EMBO J. 1992; 11: 3577–3583
   PubMed Web of Science ®Google Scholar
• Schiavo G., Rossetto O., Catsicas S., Polverino deLaureto P., DasGupta B.R., Benfenati F., Montecucco C. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J. Biol. Chem 1993; 268: 23784–23787
   PubMed Web of Science ®Google Scholar
• Schiavo G., Shone C.C., Rossetto O., Alexander F.C., Montecucco C. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J. Biol. Chem. 1993; 268: 11516–11519
   PubMed Web of Science ®Google Scholar
• Schiavo G., Shone C.C., Bennett M.K., Scheller R.H., Montecucco C. Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J. Biol. Chem. 1995; 270: 10566–10570
   PubMed Web of Science ®Google Scholar
• Schmidt J.J., Stafford R.G., Millard C.B. High-throughput assays for botulinum neurotoxin proteolytic activity: serotypes A, B, D, and F. Anal. Biochem. 2001; 296: 130–137
   PubMed Web of Science ®Google Scholar
• Schweitzer B., Stephen K. Combining nucleic acid amplification and detection. Curr. Opin. Biotech 2001; 12: 21–27
   PubMed Web of Science ®Google Scholar
• Schweitzer B., Wiltshire S., Lambert J., O’Malley S., Kukanskis K., Zhu Z., Kingsmore S.F., Lizardi P.M., Ward D.C. Immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. Proc. Natl. Acad. Sci. USA 2000; 97: 10113–10119
   PubMed Web of Science ®Google Scholar
• Sharma S.K., Eblen B.S., Bull R.L., Burr D.H., Whiting R.C. Evaluation of lateral-flow Clostridium botulinum neurotoxin detection kits for food analysis. Appl. Environ. Microbiol. 2005; 71: 3935–3941
   PubMed Web of Science ®Google Scholar
• Sharma S.K., Ferreira J.L., Eblen B.S., Whiting R.C. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies. Appl. Environ. Microbiol. 2006; 72: 1231–1238
   PubMed Web of Science ®Google Scholar
• Sharma S.K., Whiting R.C. Methods for detection of Clostridium botulinum toxin in foods. J. Food Prot. 2005; 68: 1256–1263
   PubMed Web of Science ®Google Scholar
• Sheridan R.E., Deshpande S.S, Smith T. Comparison of in vivo and in vitro mouse bioassays for botulinum toxin antagonists. J. Appl. Toxicol 1999; 19(Suppl 1)S29–33
   Google Scholar
• Sheridan R.E., Smith T.J., Adler M. Primary cell culture for evaluation of botulinum neurotoxin antagonists. Toxicon. 2005; 45: 377–382
   PubMed Web of Science ®Google Scholar
• Shone C., Ferreira J., Boyer A., Cirino N., Egan C., Evans E., Kools J., Sharma S. The 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins. Workshop review: assays and detection. Neurotox Res 2006; 9: 205–216
   PubMed Web of Science ®Google Scholar
• Shone C., Wilton-Smith P., Appleton N., Hambleton P., Modi N., Gatley S., Melling J. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse assay. Appl. Environ. Microbiol. 1985; 50: 63–67
   PubMed Web of Science ®Google Scholar
• Simpson L.L. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 1981; 33: 155–188
   PubMed Web of Science ®Google Scholar
• Simpson L.L. Identification of the major steps in botulinum toxin action. Annu Rev Pharmacol Toxicol 2004; 44: 167–193
   PubMed Web of Science ®Google Scholar
• Singer J.M., Plotz C.M. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am. J. Med. 1956; 21: 888
   PubMed Web of Science ®Google Scholar
• Singh B.R. Intimate details of the most poisonous poison. Nature Struct. Biol. 2000; 7: 617–619
   PubMedGoogle Scholar
• Singh B.R. Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting. Neurotox. Res. 2006; 9: 73–92
   PubMed Web of Science ®Google Scholar
• Singh B.R., Lopes T., Silvia M.A. Immunochemical characterization of type A botulinum neurotoxin in its purified and complexed forms. Toxicon 1996; 34: 267–275
   Google Scholar
• Singh B.R., Silvia M.A. Detection of botulinum neurotoxins using optical fiber-based biosensor. Adv. Exp. Med. Biol. 1996; 391: 499–508
   Google Scholar
• Smith T.J., Lou J., Geren I.N., Forsyth C.M., Tsai R., Laporte S.J., Tepp W.H., Bradshaw M., Johnson E.A., Smith L.A., Marks J.D. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun 2005; 73: 5450–5457
   PubMed Web of Science ®Google Scholar
• Smits H.L., Eapen C.K., Sugathan S., Kuriakose M., Gasem M.H., Yersin C., Sasaki D., Pujianto B., Vestering M., Abdoel T.H., Gussenhoven G.C. Lateral-flow assay for rapid serodiagnosis of human leptospirosis. Clin. Diagn. Lab. Immunol. 2001; 8: 166–169
   PubMedGoogle Scholar
• Sobel J., Tucker N., Sulka A., McLaughlin J., Maslanka S. Foodborne botulism in the United States, 1990–2000. Emerg Infect Dis 2004; 10: 1606–1611
   PubMed Web of Science ®Google Scholar
• Summerbell R.C., Levesque C.A., Seifert K.A., Bovers M., Fell J.W., Diaz M.R., Boekhout T., de Hoog G.S., Stalpers J., Crous P.W. Microcoding: the second step in DNA barcoding. Philos Trans R Soc Lond B Biol Sci. 2005; 360: 1897–1903
   PubMed Web of Science ®Google Scholar
• Szilagyi M., Rivera V.R., Neal D., Merrill G.A., Poli M.A. Development of sensitive colorimetric capture elisas for Clostridium botulinum neurotoxin serotypes A and B. Toxicon 2000; 38: 381–389
   PubMed Web of Science ®Google Scholar
• Takahashi M, Kameyama S., Sakaguchi G. Assay in mice for low levels of Clostridium botulinum toxin. Int. J. Food Microbiol. 1990; 11: 271–277
   Google Scholar
• Tan W, Wang K., Drake T.J. Molecular beacons. Curr. Opin. Chem. Biol 2004; 8: 547–553
   PubMed Web of Science ®Google Scholar
• Templin M.F., Stoll D., Schrenk M., Traub P.C., Vohringer C.F., Joos T.O. Protein microarray technology. Trends. in Biotech. 2002; 20: 160–166
   PubMed Web of Science ®Google Scholar
• Vignali D.A. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods. 2000; 243: 243–255
   PubMed Web of Science ®Google Scholar
• Wein L.M., Liu Y. Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk. Proc. Natl. Acad. Sci. USA 2005; 102: 9984–9989
   PubMed Web of Science ®Google Scholar
• Wictome M., Newton K.A., Jameson K., Dunnigan P., Clarke S., Gaze J., Tauk A., Foster K.A., Shone C.C. Development of an in vitro bioassay for Clostidium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay. Appl. Environ. Microbiol 1999; 65: 3787–3792
   PubMed Web of Science ®Google Scholar
• Wictome M., Newton K.A., Jameson K., Dunnigan P., Clarke S., Gaze J., Tauk A., Foster K.A., Shone C.C. Development of in vitro assays for the detection of botulinum toxins in food. FEMS Immuno. Med. Microbiol. 1999; 24: 319–323
   PubMed Web of Science ®Google Scholar
• Wittmann C., Schreiter P.Y. Analysis of terbuthylazine in soil samples by two test strip immunoassay formats using reflectance. J. Agric. Food Chem. 1999; 47: 2733–2737
   PubMedGoogle Scholar
• Wu H.C., Huang Y.L., Lai S.C., Huang Y.Y., Shaio M.F. Detection of Clostridium botulinum neurotoxin type A using immuno-PCR. Lett. Appl. Microbiol. 2001; 32: 321–325
   PubMed Web of Science ®Google Scholar
• Yamasaki S., Baumeister A., Binz T., Blasi J., Link E., Cornille F., Roques B., Fykse E.M., Sudhof T.C., Jahn R. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J. Biol. Chem. 1994; 269: 12764–12772
   PubMed Web of Science ®Google Scholar
• Yamasaki S., Binz T., Hayashi T., Szabo E., Yamasaki N., Eklund M., Jahn R., Niemann H. Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2. Biochem. Biophys. Res. Commun 1994; 200: 829–835
   Google Scholar
• Zhou C., Jiang Y., Hou S., Ma B., Fang X., Li M. Detection of oncoprotein platelet-derived growth factor using a fluorescent signaling complex of an aptamer and TOTO. Anal. Bio Chem. 2006; 384: 1175–1180
   Google Scholar
• Zhu H., Snyder M. Protein chip technology. Curr. Opin. Chem. Biol 2003; 7: 55–63
   PubMed Web of Science ®Google Scholar